Table 2. Homogenate binding studies: Bmax and Kd for HABs and LABs with [3H]PBR28 and [3H]PK11195.
| Donor | [3H]PK11195: Kd (nmol/L) and Bmax (fmol per mg protein) | [3H]PBR28: Kd (nmol/L) and Bmax (fmol per mg protein) using a single-site model | [3H]PBR28: Kd (nmol/L) and Bmax (fmol per mg protein) for two-site model, where appropriate | ||||
|---|---|---|---|---|---|---|---|
| Bmax | Kd | Bmax | Kd | Total Bmax (for both sites) | kd (High-affinity site) | Kd (Low-affinity site) | |
| HABs | |||||||
| 1 | 4998 | 16.17 | 1432 | 2.49 | |||
| 2 | 6223 | 32.39 | 2410 | 2.23 | |||
| 3 | 3003 | 29.36 | 1550 | 2.75 | |||
| 4 | 3908 | 51.72 | 1305 | 1.34 | |||
| 7 | 6263 | 42.79 | 1879 | 2.30 | |||
| 8 | 5217 | 32.03 | 1296a | 2.22a | 1479 | 1.1 | 21 |
| 9 | 4693 | 32.51 | 977a | 2.35a | 2337 | 1.48 | 374 |
| 10 | b | b | 3000 | 2.36 | |||
| 11 | 2599 | 10.18 | 1199a | 3.53a | 1709 | 1.48 | 69 |
| 12 | 2018 | 9.23 | 1305a | 2.86a | 1917 | 1.15 | 76 |
| Mean±s.d. | 4325±1540 (n=9) | 28.5±14.35 (n=9) | 1929±657 (n=6) | 2.2±0.48 (n=6) | 1861±365 (n=4) | 1.3±0.2 (n=4) | 135±161 (n=4) |
| LABs | |||||||
| 5 | 5843 | 27.44 | 1440 | 35.36 | |||
| 6 | 2765 | 18.53 | 611 | 32.42 | |||
| 20 | 5725 | 50.59 | 691 | 46.85 | |||
| 21 | 5174 | 18.83 | 985 | 89.64 | |||
| 22 | 5808 | 37.79 | 1243 | 57.58 | |||
| Mean±s.d. | 5063±1313 (n=5) | 30.6±13.65 (n=5) | 994±353 (n=5) | 52.4±23.13 (n=5) | |||
| T-test | P=0.38 | P=0.79 | P=0.02 | P<0.001 | |||
HABs, high-affinity binders; LABs, low-affinity binders.
Data did not fit a single-site model and was therefore excluded from calculation of mean Bmax and Kd.
Curve did not reach full plateau, and therefore accurate values for Kd and Bmax could not be calculated.